Mitoxantron-BP 2 mg/ml concentrat pentru soluţie perfuzabilă Moldova - Romence - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

mitoxantron-bp 2 mg/ml concentrat pentru soluţie perfuzabilă

sc balkan pharmaceuticals srl - mitoxantronum - concentrat pentru soluţie perfuzabilă - 2 mg/ml

Dimethyl fumarate Mylan Avrupa Birliği - Romence - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Avrupa Birliği - Romence - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Avrupa Birliği - Romence - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

DIMTRUZIC 120 mg Romanya - Romence - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

dimtruzic 120 mg

lek pharmaceuticals d.d. - slovenia - dimetil fumarat - caps. gastrorez. - 120mg - imunosupresoare alte imunosupresoare

DIMTRUZIC 240 mg Romanya - Romence - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

dimtruzic 240 mg

lek pharmaceuticals d.d. - slovenia - dimetil fumarat - caps. gastrorez. - 240mg - imunosupresoare alte imunosupresoare

Dimethyl fumarate Teva Avrupa Birliği - Romence - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - fumarat de dimetil - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresoare - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Avrupa Birliği - Romence - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - fumarat de dimetil - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresoare - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).